시장보고서
상품코드
1765280

세계의 치료적 혈장 교환 시장

Therapeutic Plasma Exchange

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 197 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

치료적 혈장 교환 세계 시장은 2030년까지 21억 달러에 달할 전망

2024년에 15억 달러로 추정되는 치료적 혈장 교환 세계 시장은 2024-2030년 분석 기간 동안 CAGR 6.2%로 성장하여 2030년에는 21억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 신경질환은 CAGR 6.9%를 기록하며 분석 기간 종료시에는 7억 8,960만 달러에 달할 것으로 예측됩니다. 신손상 분야의 성장률은 분석 기간 동안 CAGR 5.3%로 추정됩니다.

미국 시장은 4억 1,010만 달러로 추정, 중국은 CAGR 5.7%로 성장 예측

미국의 치료적 혈장 교환 시장은 2024년에 4억 1,010만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 5.7%로 성장하여 2030년까지 3억 3,170만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 5.5%와 5.1%로 예측됩니다. 유럽에서는 독일이 CAGR 4.6%로 성장할 것으로 예측됩니다.

세계의 치료적 혈장 교환 시장 - 주요 동향과 촉진요인 정리

현대 의료에서 치료적 혈장 교환이 중요한 이유는 무엇일까?

치료적 혈장 교환(TPE)은 다양한 자가면역질환, 혈액질환, 신경질환의 치료에서 생명을 구하는 치료법으로 등장했습니다. 이 방법은 환자의 혈액에서 혈장을 제거하고 신선한 혈장 또는 혈장 대체물로 대체하여 유해한 항체와 독소를 제거하는 데 도움이 됩니다. 길랭 바레 증후군, 중증근무력증, 다발성 경화증 등의 치료에 TPE의 사용이 증가함에 따라 의료 분야에서 TPE의 중요한 역할이 강조되고 있습니다. 혈장 교환의 이점에 대한 인식이 높아지면서 더 많은 환자와 의료 서비스 제공자가 이 치료법을 사용함에 따라 치료적 혈장 교환 시장은 최근 몇 년 동안 크게 성장했습니다.

다양한 용도와 기술이 어떻게 시장을 주도하고 있는가?

기술별로는 원심분리법과 막여과법이 가장 일반적으로 사용되는 방법이며, 각각 뚜렷한 장점이 있습니다. 원심분리 기반 시스템은 신경 질환 치료에 널리 사용되는 반면, 막여과는 신장 질환 및 특정 혈액 질환에 선호됩니다. 적응 질환은 자가 면역 질환에서 혈액 질환, 기타 심각한 질환에 이르기까지 다양합니다. 최종사용자별로는 병원, 전문 클리닉, 헌혈 센터가 시장을 지배하고 있으며, 만성질환 관리를 위해 TPE 시술을 채택하는 외래 환자 시설이 증가하고 있으며, TPE를 도입한 치료 옵션이 증가함에 따라 전체 시장의 저변이 확대되고 있습니다.

어떤 혁신이 치료적 혈장 교환의 미래를 형성하고 있는가?

기술의 발전으로 보다 효율적이고 안전하며 사용하기 쉬운 혈장 교환 시스템이 개발되어 혈장 교환이 의료 서비스 제공자에게 더욱 친숙해졌습니다. 강화된 안전 기능을 갖춘 자동화된 아펠레시스 장치는 점점 더 표준 치료법이 되어가고 있으며, 시술 시간을 단축하고 환자 결과를 개선하고 있습니다. 또한, TPE 시스템에 통합된 실시간 모니터링 및 데이터 분석 기능을 통해 의료진은 환자별 상태에 따라 맞춤형 치료를 할 수 있게 되었습니다. 또한, 면역억제요법 등 다른 치료법과 결합하는 경향이 강화되면서 만성질환 관리의 양상을 바꾸고 있습니다.

치료적 혈장 교환 시장의 성장 촉진요인은?

치료적 혈장 교환 시장의 성장은 자가면역질환의 유병률 증가, 신경질환 치료에 TPE의 사용 증가, 새로운 혈장교환기 승인 증가 등 여러 요인에 기인하고 있습니다. 의료 인프라에 대한 투자 증가와 함께 아펠레시스 장치의 기술 혁신은 TPE의 채택을 확대하고 있습니다. 또한, 중증 의료 환경에서 TPE를 통한 조기 개입의 이점에 대한 의료 전문가들의 인식이 높아짐에 따라 혈장 교환에 대한 수요가 증가하고 있습니다. 특히 희귀하고 복잡한 질병을 치료하기 위해 TPE를 사용할 수 있는 환자층이 확대되면서 시장 성장을 더욱 촉진하고 있습니다. 마지막으로, 휴대가 가능하고 비용 효율적인 혈장 교환 시스템의 개발로 인해 이 생명을 구하는 치료법이 더욱 친숙해지면서 향후 몇 년 동안 시장이 확대될 것으로 예상됩니다.

부문

적응 질환(신경질환, 신장질환, 혈액질환, 대사질환, 기타 질환), 최종 용도(병원, 전문 클리닉, 외래 수술 센터)

조사 대상 기업 사례

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범에 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.07.15

Global Therapeutic Plasma Exchange Market to Reach US$2.1 Billion by 2030

The global market for Therapeutic Plasma Exchange estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Neurological Disorders, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million by the end of the analysis period. Growth in the Renal Disorders segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$410.1 Million While China is Forecast to Grow at 5.7% CAGR

The Therapeutic Plasma Exchange market in the U.S. is estimated at US$410.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$331.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Therapeutic Plasma Exchange Market - Key Trends and Drivers Summarized

What Makes Therapeutic Plasma Exchange Critical in Modern Healthcare?

Therapeutic plasma exchange (TPE) has emerged as a life-saving procedure in treating various autoimmune diseases, hematological conditions, and neurological disorders. This procedure involves the removal of plasma from a patient's blood and its replacement with fresh plasma or a plasma substitute, which helps eliminate harmful antibodies and toxins. The increasing use of TPE in treating conditions such as Guillain-Barre syndrome, myasthenia gravis, and multiple sclerosis has underscored its critical role in healthcare. As awareness of the benefits of plasma exchange grows, more patients and healthcare providers are turning to this therapy, which has significantly expanded the therapeutic plasma exchange market in recent years.

How Are Different Applications and Technologies Driving the Market?

By technology, centrifugal-based and membrane filtration techniques are the most commonly employed methods, each offering distinct advantages. Centrifugal-based systems are widely used in treating neurological conditions, whereas membrane filtration is preferred for renal disorders and certain hematological diseases. Disease indication segments range from autoimmune disorders to blood dyscrasias and other critical illnesses. In terms of end-users, hospitals, specialty clinics, and blood donation centers dominate the market, with a growing number of outpatient facilities adopting TPE procedures for chronic disease management. The rising number of treatment options that incorporate TPE is expanding the market’s overall reach.

What Innovations Are Shaping the Future of Therapeutic Plasma Exchange?

Technological advancements have led to more efficient, safe, and user-friendly plasma exchange systems, making the procedure more accessible to healthcare providers. Automated apheresis devices, equipped with enhanced safety features, are increasingly becoming the standard of care, reducing procedure time and improving patient outcomes. Moreover, the integration of real-time monitoring and data analytics in TPE systems allows healthcare providers to customize treatments based on patient-specific conditions. Additionally, the growing trend of combining therapeutic plasma exchange with other treatment modalities, such as immunosuppressive therapies, is transforming the landscape of chronic disease management.

What Are the Key Drivers of Growth in the Therapeutic Plasma Exchange Market?

The growth in the therapeutic plasma exchange market is driven by several factors, including the rising prevalence of autoimmune diseases, the increased use of TPE in treating neurological conditions, and the growing number of regulatory approvals for novel plasma exchange devices. Technological innovations in apheresis devices, coupled with rising investments in healthcare infrastructure, are expanding the adoption of TPE. Additionally, increasing awareness among healthcare professionals about the benefits of early intervention with TPE in critical care settings is boosting the demand for plasma exchange. The expanding base of patients eligible for TPE, particularly in the treatment of rare and complex disorders, further propels market growth. Lastly, the development of portable and more cost-effective plasma exchange systems is expected to make this life-saving therapy more accessible, driving market expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Therapeutic Plasma Exchange market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders, Other Disease Indications); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 47 Featured) -

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Therapeutic Plasma Exchange - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Autoimmune Diseases Propels Growth of Therapeutic Plasma Exchange Market
    • Rising Demand for Non-invasive Therapeutic Solutions Strengthens Adoption of Plasma Exchange
    • Increasing Application of Therapeutic Plasma Exchange in Neurological Disorders Expands Market Opportunity
    • Advances in Medical Device Technologies Drive the Efficiency of Plasma Exchange Systems
    • Growing Use of Therapeutic Plasma Exchange in Pediatric Applications Spurs Market Growth
    • Rising Focus on Plasma-based Treatments for Critical Illnesses Drives Adoption of Therapeutic Plasma Exchange
    • Technological Innovations in Apheresis Systems Generate Demand for Advanced Plasma Exchange Solutions
    • Increased Awareness of Plasma Donation Programs Expands Adoption of Plasma Exchange Treatments
    • Growing Number of Plasma Collection Centers Propels the Therapeutic Plasma Exchange Market
    • Integration of AI and Data Analytics in Plasma Exchange Systems Strengthens Operational Efficiency
    • Surge in Clinical Trials Exploring Plasma Exchange for Emerging Therapies Boosts Market Demand
    • Increasing Use of Plasma Exchange in Immunology and Hematology Drives Market Expansion
    • Rising Prevalence of Infectious Diseases Spurs Demand for Plasma-based Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Therapeutic Plasma Exchange Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Therapeutic Plasma Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Therapeutic Plasma Exchange by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Renal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Renal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Renal Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hematology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hematology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hematology Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Metabolic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Therapeutic Plasma Exchange by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Therapeutic Plasma Exchange by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제